Clinical trials: Erythematotelangiectatic Rosacea
Erythematotelangiectatic Rosacea
Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea
This is a randomized, double-blind, parallel-group, vehicle-controlled, dose-finding study to investigate the pharmacodynamics and the safety of three dosages of CD07805/47 topical gel (0.07%, 0.18%, and 0.50%), after a single…
- Trial name
- NCT00989014
- Testing
- CD07805/47
- Where
- 5 sites in United States
- Volunteers
- 122 people
- Sponsor
- Galderma R&D
Rosacea
Brimonidine in Rosacea
Rosacea is a chronic and relapsing inflammatory cutaneous disorder with highly variable prevalence worldwide.
- Trial name
- NCT05401422
- Testing
- treatment
- Volunteers
- 45 people
- Sponsor
- Cairo University
Erythematotelangiectatic Rosacea, Papulopustular Rosacea
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea
A single center prospective, randomized, controlled split face study comparing a 532nm KTP laser with a 595nm PDL for the treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea.
- Trial name
- NCT02268474
- Testing
- 532nm KTP Laser vs 595nm Pulse Dye Laser
- Where
- United States
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Cutera Inc.
Erythematotelangiectatic Rosacea, Papulopustular Rosacea
Open Label Pilot Study of Apremilast in Treatment of Rosacea
Rosacea is a chronic skin disorder with the signs and symptoms of facial flushing, persistent redness, small visible spider-like veins, papules (inflamed red bumps under the skin) and pustules.
- Trial name
- NCT01045551
- Testing
- Apremilast
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Julian M. Mackay-Wiggan
Erythematotelangiectatic Rosacea, Papulopustular Rosacea
Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients
The objective of this study is to determine the efficacy and safety of PAC-14028 1% cream of Amorepacific Corporation in patients with erythema-telangiectatic or papulopustular rosacea
- Trial name
- NCT02052999
- Testing
- PAC-14028 cream 1%, Vehicle, Rozex gel 0.75%
- Where
- South Korea
- Volunteers
- 80 people
- Sponsor
- Amorepacific Corporation
Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Brimonidine 0.33% for Rosacea-Related Facial Erythema
This study looks at whether a topical gel called 0.33% brimonidine can reduce persistent facial redness caused by rosacea. The study was carried out in two parts.
- Trial name
- NCT07431476
- Testing
- Brimonidine 0.33% gel
- Where
- Turkey (Türkiye)
- Volunteers
- 45 people
- Sponsor
- Istanbul Training and Research Hospital
Erythematotelangiectatic Rosacea
Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea
Rosacea is a frequent dermatological condition, with a chronic and disturbing evolution that is characterized by redness, permanent erythema associated with telangiectasia (visible and permanent dilatation of the small vessels).
- Trial name
- ROSAPHOTOLASE (NCT03708263)
- Testing
- Excel V 532nm (KTP) green Laser, PHOTOLASE PLV 585 nm yellow laser
- Where
- France
- Volunteers
- 1 people
- Sponsor
- University Hospital, Lille
Erythematotelangiectatic Rosacea
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
This study will compare treatment outcome with pulsed dye laser, when used used as an adjunctive treatment to oxymetazoline HCl 1% cream, compared to oxymetazoline HCL 1% cream alone, for patients with moderate or severe…
- Trial name
- NCT04153188
- Testing
- The Vbeam® Prima System, Oxymetazoline HCL 1% Cream
- Where
- 2 sites in United States
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- Candela Corporation
Rosacea, Erythematotelangiectatic
Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea
This is a prospective, vehicle controlled, double blinded study to evaluate the safety and potential efficacy of a topical formulation of a MEK inhibitor in patients with erythematotelangiectatic rosacea
- Trial name
- TOMIR (NCT05616923)
- Testing
- Trametinib
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Albany Research Institute, Inc.
Rosacea, Erythematotelangiectatic
Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions
The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the erythema of the face and telangiectasia.
- Trial name
- Nd:YAG (NCT06908915)
- Testing
- Nd:YAG laser 1064 nm
- Where
- Iraq
- Volunteers
- 30 people
- Sponsor
- Hawler Medical University
Erythematotelangiectatic Rosacea
Feasibility Study: Ulthera System for the Treatment of Rosacea
Up to 12 subjects will be enrolled. Enrolled subjects will receive one or two Ultherapy treatments on the cheeks, depending on their assigned study group. Follow-up visits will occur 14, 30 and 90 days post-treatment.
- Trial name
- NCT01756027
- Testing
- Ulthera System providing one treatment per cheek, Ulthera System providing two treatments per cheek
- Where
- Canada
- Volunteers
- 12 people
- Sponsor
- Ulthera, Inc
Erythematotelangiectatic Rosacea
Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea
Investigation of the effectiveness of intradermal botulinum toxin A treatment in the treatment of erythematotelangiectatic rosacea (ETR) using clinical, biophysical, dermatoscopic and videocapillaroscopy.
- Trial name
- NCT06331533
- Testing
- Botulinum toxin A
- Where
- Turkey (Türkiye)
- Volunteers
- 30 people
- Sponsor
- Istanbul Training and Research Hospital
Erythematotelangiectatic Rosacea, Rosacea
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
This is a prospective, multi-site (up to 5 sites), single-blinded, randomized trial. Up to 88 subjects will be enrolled and randomized to one of four treatment groups (4 Groups of 22 subjects), and will receive study treatments…
- Trial name
- NCT02144181
- Testing
- Ulthera System Treatment
- Where
- 5 sites in United States, Canada
- Volunteers
- 88 people, healthy volunteers welcome
- Sponsor
- Ulthera, Inc
Rosacea
Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea
This study compares three approaches to treating persistent facial redness in adults with erythematotelangiectatic rosacea: intense pulsed light (IPL) treatment alone, a professional anti-redness dermocosmetic skincare regimen…
- Trial name
- NCT07729540
- Testing
- Intense Pulsed Light (IPL) - Lumecca, Rosacure anti-redness dermocosmetic regimen
- Where
- Poland
- Volunteers
- 60 people
- Sponsor
- Medical University of Silesia
Erythematotelangiectatic Rosacea
The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea
The efficacy and safety of anti-inflammation treatment (Hirudoid introduction followed by yellow light therapy) combined with tofacitinib and doxycycline in Chinese adult patients with mild to moderate erythematous telangiectatic…
- Trial name
- NCT07343635
- Testing
- Doxycycline, Hydroxychloroquine, Tofacitinib
- Where
- China
- Volunteers
- 186 people
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Rosacea
Effect of CD07805/47 Gel in Rosacea Flushing
Phase 2a study to assess the efficacy and safety of CD07805/47 0.5% gel in the prevention of the flush of rosacea.
- Trial name
- NCT02300129
- Where
- Germany
- Volunteers
- 34 people
- Sponsor
- Galderma R&D
Erythematotelangiectatic Rosacea
Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematotelangiectatic Rosacea
Pulsed dye laser(PDL) and intense pulsed light(IPL) has been widely used in improving rosacea. To compare the efficacy and safety of PDL and IPL configured with different wavelength bands(Delicate Pulsed Light, M22 590, M22…
- Trial name
- NCT05360251
- Testing
- PDL(595nm), IPL(DPL), IPL(M22 590)
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial
The goal of this clinical trial is to learn if Gabapentin works to treat flushing/erythema associated with rosacea. It will also learn about the safety of drug Gabapentin.
- Trial name
- Gabapenti (NCT06776445)
- Testing
- minocycline combined with hydroxychloroquine, gabapentin 300mg bid, gabapentin 300mg tid
- Where
- China
- Volunteers
- 50 people
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
Rosacea
A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155)
This study will assess the effect of MK-0524 relative to placebo, on signs and symptoms of rosacea and to determine the safety and tolerability profile of MK-0524 in participants with rosacea.
- Trial name
- NCT01451619
- Testing
- Laropiprant
- Volunteers
- 60 people
- Sponsor
- Merck Sharp & Dohme LLC
Papulopustular Rosacea, Erythematotelangiectatic Rosacea
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.
- Trial name
- NCT02393937
- Testing
- Reference: Metronidazole Gel 1%, Test: Metronidazole Gel 1%
- Where
- 27 sites in United States
- Volunteers
- 963 people
- Sponsor
- bioRASI, LLC